Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Innoviva Inc. diskutieren

Innoviva Inc.

WKN: A2AC9U / Symbol: INVA / Name: Innoviva / Aktie / Pharmazeutika / Small Cap /

18,10 €
-0,55 %

Einschätzung Buy
Rendite (%) 32,69 %
Kursziel 21,21
Veränderung
Endet am 03.03.24

Innoviva, Inc. (NASDAQ: INVA) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $22.50 price target on the stock.
Ratings data for INVA provided by MarketBeat

Einschätzung Sell
Rendite (%) 32,69 %
Kursziel 9,43
Veränderung
Endet am 03.03.24

Innoviva, Inc. (NASDAQ: INVA) had its price target lowered by analysts at Morgan Stanley from $13.00 to $10.00. They now have an "underweight" rating on the stock.
Ratings data for INVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 29,91 %
Kursziel 20,50
Veränderung
Endet am 20.04.24

Innoviva, Inc. (NASDAQ: INVA) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $22.50 price target on the stock.
Ratings data for INVA provided by MarketBeat

Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for INVA provided by MarketBeat

Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for INVA provided by MarketBeat

Innoviva, Inc. (NASDAQ: INVA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for INVA provided by MarketBeat

Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for INVA provided by MarketBeat

Innoviva, Inc. (NASDAQ: INVA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for INVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 12,27 %
Kursziel 22,27
Veränderung
Endet am 11.07.26

Innoviva, Inc. (NASDAQ: INVA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $26.00 price target on the stock.
Ratings data for INVA provided by MarketBeat

Innoviva (NASDAQ:INVA) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for INVA provided by MarketBeat

Innoviva (NASDAQ:INVA) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for INVA provided by MarketBeat

Innoviva (NASDAQ:INVA) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for INVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,23 %
Kursziel 26,94
Veränderung
Endet am 06.11.26

Innoviva (NASDAQ:INVA) had its price target raised by analysts at Cantor Fitzgerald from $29.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for INVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,28 %
Kursziel 39,15
Veränderung
Endet am 16.12.26

Innoviva (NASDAQ:INVA) had its price target raised by analysts at HC Wainwright from $45.00 to $46.00. They now have a "buy" rating on the stock.
Ratings data for INVA provided by MarketBeat